US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 25.330
  • -0.550-2.13%
Close Jul 26 16:00 ET
  • 25.330
  • 0.0000.00%
Post 20:01 ET
2.30BMarket Cap-8887P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rocket Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.66

+9.59%
Analyst Rating

Strong Buy

Jul 4, 2024

Rocket Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 888.890K--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 888.890K--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Rocket Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 7 16:58 ET

  • Rocket Pharmaceuticals | 10-K: Annual report

    Feb 27 16:14 ET

  • Rocket Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 16:40 ET

  • Rocket Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 17:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 4, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg